Allen Annis - Mar 30, 2022 Form 4/A - Amendment Insider Report for AILERON THERAPEUTICS INC (ALRN)

Role
SVP, Research
Signature
/s/ Richard Wanstall, attorney in fact for David Allen Annis
Stock symbol
ALRN
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/30/2022, 08:31 PM
Date Of Original Report
Mar 24, 2022
Previous filing
Mar 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALRN Stock Option (right to buy) Award $0 +313K $0.00 313K Mar 30, 2022 Common Stock 313K $0.48 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the date of grant and the exercise price for the stock option reported on a Form 4 filed by the reporting person on March 24, 2022. This option became effective on March 30, 2022.
F2 The shares underlying the option are scheduled to vest in equal monthly installments through March 30, 2026.